Erica S Shenoy

InstitutionHarvard Medical School
AddressBoston
Massachusetts
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 17 Covid-19 publications, with a maximum of 3 publications in August 2020
    All Publications
    Bar chart showing 50 publications over 10 distinct years, with a maximum of 9 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dugdale CM, Rubins DM, Lee H, McCluskey SM, Ryan ET, Kotton CN, Hurtado RM, Ciaranello AL, Barshak MB, McEvoy DS, Nelson SB, Basgoz N, Lazarus JE, Ivers LC, Reedy JL, Hysell KM, Lemieux JE, Heller HM, Dutta S, Albin JS, Brown TS, Miller AL, Calderwood SB, Walensky RP, Zachary KC, Hooper DC, Hyle EP, Shenoy ES. Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator). Clin Infect Dis. 2021 12 16; 73(12):2248-2256. PMID: 33564833.
      Citations: 4     Fields:    Translation:HumansAnimals
    2. Robinson LB, Fu X, Hashimoto D, Wickner P, Shenoy ES, Landman AB, Blumenthal KG. Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines. JAMA Dermatol. 2021 08 01; 157(8):1000-1002. PMID: 34160555.
      Citations: 2     Fields:    Translation:Humans
    3. Weber DJ, Al-Tawfiq JA, Babcock HM, Bryant K, Drees M, Elshaboury R, Essick K, Fakih M, Henderson DK, Javaid W, Juffras D, Jump RLP, Lee F, Malani AN, Mathew TA, Murthy RK, Nace D, O'Shea T, Pettigrew E, Pettis AM, Schaffzin JK, Shenoy ES, Vaishampayan J, Wiley Z, Wright SB, Yokoe D, Young H. Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnel. Infect Control Hosp Epidemiol. 2022 01; 43(1):3-11. PMID: 34253266.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    4. Robinson LB, Landman AB, Shenoy ES, Hashimoto D, Fu X, Camargo CA, Wickner P, Blumenthal KG. Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination. J Allergy Clin Immunol Pract. 2021 08; 9(8):3200-3202.e1. PMID: 34126274.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    5. Egbuonu K, Hyle EP, Hurtado RM, Alba GA, Zachary KC, Branda JA, Hibbert KA, Hooper DC, Shenoy ES, Turbett SE, Dugdale CM. Yield of Severe Acute Respiratory Syndrome Coronavirus 2 Lower Respiratory Tract Testing After a Negative Nasopharyngeal Test Among Hospitalized Persons Under Investigation for Coronavirus Disease 2019. Open Forum Infect Dis. 2021 Jun; 8(6):ofab257. PMID: 34113690.
      Citations:    
    6. Blumenthal KG, Robinson LB, Camargo CA, Shenoy ES, Banerji A, Landman AB, Wickner P. Acute Allergic Reactions to mRNA COVID-19 Vaccines. JAMA. 2021 04 20; 325(15):1562-1565. PMID: 33683290.
      Citations: 43     Fields:    Translation:Humans
    7. Blumenthal KG, Freeman EE, Saff RR, Robinson LB, Wolfson AR, Foreman RK, Hashimoto D, Banerji A, Li L, Anvari S, Shenoy ES. Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2. N Engl J Med. 2021 04 01; 384(13):1273-1277. PMID: 33657292.
      Citations: 47     Fields:    Translation:Humans
    8. Shenoy ES, Weber DJ. Lessons learned in infection prevention for Ebola virus disease and the coronavirus disease 2019 (COVID-19) pandemic-Principles underlying prevention. Infect Control Hosp Epidemiol. 2021 04; 42(4):457-460. PMID: 33427132.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. Shenoy ES, Weber DJ. Routine surveillance of asymptomatic healthcare personnel for severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Not a prevention strategy. Infect Control Hosp Epidemiol. 2021 05; 42(5):592-597. PMID: 33427148.
      Citations: 5     Fields:    Translation:Humans
    10. Dugdale CM, Anahtar MN, Chiosi JJ, Lazarus JE, McCluskey SM, Ciaranello AL, Gogakos T, Little BP, Branda JA, Shenoy ES, Walensky RP, Zachary KC, Hooper DC, Turbett SE, Hyle EP. Clinical, Laboratory, and Radiologic Characteristics of Patients With Initial False-Negative Severe Acute Respiratory Syndrome Coronavirus 2 Nucleic Acid Amplification Test Results. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa559. PMID: 34164560.
      Citations: 4     
    11. Sánchez SM, Searle EF, Rubins D, Dutta S, Ware W, Biddinger PD, Shenoy ES. Travel-screening documentation to enable the "Identify-Isolate-Inform" framework for emerging infectious diseases: It's all in the details. Infect Control Hosp Epidemiol. 2020 12; 41(12):1449-1451. PMID: 32847641.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    12. Shenoy ES, West LR, Hooper DC, Sheehan RR, Hashimoto D, Boukus ER, Aurora MN, McEvoy DS, Klompas M. Healthcare worker infection with SARS-CoV-2 and test-based return to work. Infect Control Hosp Epidemiol. 2020 12; 41(12):1464-1466. PMID: 32843110.
      Citations:    Fields:    Translation:HumansPHPublic Health
    13. Dugdale CM, Turbett SE, McCluskey SM, Zachary KC, Shenoy ES, Ciaranello AL, Walensky RP, Rosenberg ES, Anahtar MN, Hooper DC, Hyle EP. Outcomes from an infectious disease physician-guided evaluation of hospitalized persons under investigation for coronavirus disease 2019 (COVID-19) at a large US academic medical center. Infect Control Hosp Epidemiol. 2021 03; 42(3):344-347. PMID: 32829726.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    14. Klompas M, Morris CA, Shenoy ES. Universal Masking in the Covid-19 Era. N Engl J Med. 2020 07 09; 383(2):e9. PMID: 32492295.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    15. Goldfarb IT, Diouf K, Barth WH, Robinson JN, Katz D, Gregory KE, Ciaranello A, Yawetz S, Shenoy ES, Klompas M. Universal SARS-CoV-2 testing on admission to the labor and delivery unit: Low prevalence among asymptomatic obstetric patients. Infect Control Hosp Epidemiol. 2020 Sep; 41(9):1095-1096. PMID: 32456729.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    16. Klompas M, Morris CA, Sinclair J, Pearson M, Shenoy ES. Universal Masking in Hospitals in the Covid-19 Era. N Engl J Med. 2020 May 21; 382(21):e63. PMID: 32237672.
      Citations: 84     Fields:    Translation:HumansCellsPHPublic Health
    Shenoy's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (122)
    Explore
    _
    Co-Authors (98)
    Explore
    _
    Similar People (60)
    Explore
    _